- Products & Services
- Knowledge Base
We are in a position where our business and humanitarian instincts can intersect. This is positive for all concerned.
NEW YORK, NY, May 11, 2020 /24-7PressRelease/ -- Despite wild stock fluctuations due to the economic slowdown throughout March and April of this year, SB Capital Management Inc. has taken the opportunity to greatly expand its investment portfolio. Under the resolute leadership of Levi Russell and Nguyen Van Anh, SB Capital has displayed particular interest in healthcare companies and airlines affected—positively or negatively—by the COVID-19 pandemic. These are investments the firm feels will offer long term opportunities for its clients, as well as the future of SB Capital Management Inc.
SB Capital's portfolio now includes significant holdings in up-and-comers Moderna, Inc. (NASDAQ: MRNA) and Inovio (NASDAQ: INO), as well as premier blue-chip stocks like Johnson and Johnson (NYSE: JNJ), all of whose current focus is the creation and mass-production of a COVID-19 vaccine. In the global race to cure this deadly virus, SB Capital has modified its investment strategy to include these top three pharmaceutical candidates.
"There are more than a dozen leading companies all striving to accomplish the same goal," says Levi Russel, Co-Founder and President of SB Capital Management Inc. "But these are among the most attractive based on our internal analytics as well as our gut feeling."
This rare combination of analytical prowess and instinctive acumen has served SB Capital well in the past, resulting in their enviable track record of investments, perhaps chief amongst them their aviation and airline holdings. As Novel Coronavirus spreads globally, the world has seen airline, aerospace and aviation stocks sink to lows not seen since the post-2008 economic recovery. Despite the current state of air travel, most will readily admit that it is hard to imagine a world in which this century-old, essential mode of transportation never recovers. SB Capital strongly believes there is room for massive growth and has doubled down on its confidence for companies like American Airlines (NASDAQ: AAL), one of the hardest-hit companies of them all. SB Capital feels this is an exciting and likely profitable investment prospect for the firm and its clientele.
SB Capital's CEO, Nguyen Van Anh explains: "We believe that for many of these companies the only way to go is up—even if it takes some time."
Mr. Nguyen and Mr. Russel are both excited about the recent acquisition and opening of the SBVINA Company, a large-scale manufacturing operation for the Asian market, specializing in high demand products. SBVINA's offerings will include both standard and N95 face masks, plastic gloves and alcohol-based hand sanitizer for hospitals.
"Many of these specific items are unavailable anywhere else right now," explains Mr. Nguyen. "We are in a position where our business and humanitarian instincts can intersect. This is positive for all concerned."
To that end, SB Capital Management Inc. has also been significantly increasing their charitable efforts in recent months. With people all over the world still in quarantine and sometimes even financial distress, a central objective of SB Capital has been to give back to the people. A recent company charity event in Viet Nam yielded extraordinary results as it offered relief to those in need. These contributions included food, basic supplies and over 10,000 protective face masks.
SB Capital Management Inc. maintains a positive outlook for the post-COVID world, and will continue to customize its unique financial strategy to ensure long term opportunity for its investors.
To learn more about SB Capital Management Inc., please visit our website at www.sbcapitalmanagementinc.com
Disclaimer: SB Capital Management Inc. appears throughout the following statement as "The Company" or "Company". Certain information set forth in this presentation contains "forward-looking information", including "future oriented financial information" and "financial outlook", under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company's business, projects and joint ventures; (iv) execution of the Company's vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company's projects; (vi) completion of the Company's projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company's current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management's beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment.
These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements.
Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.
# # #